C

China Molybdenum Co Ltd
HKEX:3993

Watchlist Manager
China Molybdenum Co Ltd
HKEX:3993
Watchlist
Price: 16.37 HKD -0.79%
Market Cap: HK$353.6B

Wall St Price Targets

Price Targets Summary
China Molybdenum Co Ltd

Wall Street analysts forecast China Molybdenum Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Molybdenum Co Ltd is 22.27 HKD with a low forecast of 18.74 HKD and a high forecast of 27.47 HKD.

Lowest Forecast
Price Target
18.74 HKD
14% Upside
Average Forecast
Price Target
22.27 HKD
36% Upside
Highest Forecast
Price Target
27.47 HKD
68% Upside
China Molybdenum Co Ltd Competitors:
Price Targets
CLF
Cleveland-Cliffs Inc
3% Upside

Revenue
Forecast

32% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss
32% / Year
Past Growth
8% / Year
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Over the last 13 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 3 years is 8%.

Gross Profit
Forecast

31% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
31% / Year
Past Growth
18% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 3 years is 18%.

Operating Income
Forecast

34% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss
34% / Year
Past Growth
14% / Year
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Over the last 13 years, the compound annual growth rate for Operating Income has been 34%. The projected CAGR for the next 3 years is 14%.

Pre-Tax Income
Forecast

31% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
31% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 31%. The projected CAGR for the next 3 years is 25%.

Net Income
Forecast

26% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss
26% / Year
Past Growth
24% / Year
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Over the last 13 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 24%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is China Molybdenum Co Ltd's stock price target?
Price Target
22.27 HKD

According to Wall Street analysts, the average 1-year price target for China Molybdenum Co Ltd is 22.27 HKD with a low forecast of 18.74 HKD and a high forecast of 27.47 HKD.

What is the Revenue forecast for China Molybdenum Co Ltd?
Projected CAGR
8%

Over the last 13 years, the compound annual growth rate for Revenue has been 32%. The projected CAGR for the next 3 years is 8%.

What is the Gross Profit forecast for China Molybdenum Co Ltd?
Projected CAGR
18%

Over the last 13 years, the compound annual growth rate for Gross Profit has been 31%. The projected CAGR for the next 3 years is 18%.

What is the Operating Income forecast for China Molybdenum Co Ltd?
Projected CAGR
14%

Over the last 13 years, the compound annual growth rate for Operating Income has been 34%. The projected CAGR for the next 3 years is 14%.

What is the Pre-Tax Income forecast for China Molybdenum Co Ltd?
Projected CAGR
25%

Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 31%. The projected CAGR for the next 3 years is 25%.

What is the Net Income forecast for China Molybdenum Co Ltd?
Projected CAGR
24%

Over the last 13 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 3 years is 24%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett